title: The incidence and quantity of antiidiotypic antibody formation after OKT3 monoclonal therapy in heart-transplant recipients.
authors.affiliation: Department of Internal Medicine I, Erasmus University, Rotterdam, The Netherlands.
authors.forename: C J
authors.initials: CJ
authors.lastname: Hesse
authors.forename: P
authors.initials: P
authors.lastname: Heyse
authors.forename: B J
authors.initials: BJ
authors.lastname: Stolk
authors.forename: A H
authors.initials: AH
authors.lastname: Balk
authors.forename: N H
authors.initials: NH
authors.lastname: Jutte
authors.forename: B
authors.initials: B
authors.lastname: Mochtar
authors.forename: W
authors.initials: W
authors.lastname: Weimar
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000032:analysis*; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003524:Cyclosporins / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy; D016853:Muromonab-CD3; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D016853:Muromonab-CD3; D001379:Azathioprine; D011241:Prednisone